(19)
(11) EP 4 798 707 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883419.4

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
C12N 9/12(2006.01)
C12N 15/113(2010.01)
A61K 48/00(2006.01)
G01N 33/573(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; A61K 40/15; C12N 5/0646; C12N 2510/00; C12N 15/90; C12N 2310/20; C12N 9/1276; A61K 40/33; A61K 40/11; A61K 40/4202
(86) International application number:
PCT/US2024/053018
(87) International publication number:
WO 2025/090906 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 25.10.2023 US 202363593035 P

(71) Applicant: Baylor College of Medicine
Houston, TX 77030 (US)

(72) Inventors:
  • MAMONKIN, Maksim
    Houston, Texas 77030 (US)
  • TSAI, Chiou-Tsun
    Houston, Texas 77030 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) THERAPEUTIC CELLS WITH CONTROLLED PROLIFERATION AND METHODS OF USE